<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Verschoor CP</submitter><funding>NIA NIH HHS</funding><funding>National Institutes of Health</funding><pagination>753767</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9015675</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Influenza-specific cytolytic T lymphocytes (CTL) have a critical role in clearing the virus from the lungs, but are poorly stimulated by current inactivated influenza vaccines. Our previous work suggests that granzyme B (GrB) activity predicts protection against laboratory-confirmed influenza infection (LCII) in older adults. However, basal GrB (bGrB) activity increases with age and the frequency of GrB&lt;sup>+&lt;/sup> CTL that do not co-express perforin increases following influenza infection, thereby acting as a potential contributor to immune pathology.&lt;h4>Objectives&lt;/h4>Using data from a 4-year randomized trial of standard- versus high-dose influenza vaccination, we sought to determine whether measurements of GrB activity alone indicate a protective vs. pathologic respon</pubmed_abstract><journal>Frontiers in aging</journal><pubmed_title>Granzyme B: a double-edged sword in the response to influenza infection in vaccinated older adults.</pubmed_title><pmcid>PMC9015675</pmcid><funding_grant_id>P30 AG067988</funding_grant_id><funding_grant_id>R01 AG048023</funding_grant_id><pubmed_authors>Verschoor CP</pubmed_authors><pubmed_authors>Haynes L</pubmed_authors><pubmed_authors>Kuchel GA</pubmed_authors><pubmed_authors>McElhaney JE</pubmed_authors><pubmed_authors>Pawelec G</pubmed_authors><pubmed_authors>Loeb M</pubmed_authors><pubmed_authors>Andrew MK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Granzyme B: a double-edged sword in the response to influenza infection in vaccinated older adults.</name><description>&lt;h4>Background&lt;/h4>Influenza-specific cytolytic T lymphocytes (CTL) have a critical role in clearing the virus from the lungs, but are poorly stimulated by current inactivated influenza vaccines. Our previous work suggests that granzyme B (GrB) activity predicts protection against laboratory-confirmed influenza infection (LCII) in older adults. However, basal GrB (bGrB) activity increases with age and the frequency of GrB&lt;sup>+&lt;/sup> CTL that do not co-express perforin increases following influenza infection, thereby acting as a potential contributor to immune pathology.&lt;h4>Objectives&lt;/h4>Using data from a 4-year randomized trial of standard- versus high-dose influenza vaccination, we sought to determine whether measurements of GrB activity alone indicate a protective vs. pathologic respon</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-09T15:23:43.181Z</modification><creation>2024-11-07T13:45:03.605Z</creation></dates><accession>S-EPMC9015675</accession><cross_references><pubmed>35441156</pubmed><doi>10.3389/fragi.2021.753767</doi></cross_references></HashMap>